Ignite Creation Date:
2024-05-06 @ 2:02 PM
Last Modification Date:
2024-10-26 @ 1:24 PM
Study NCT ID:
NCT04198311
Status:
UNKNOWN
Last Update Posted:
2022-10-10
First Post:
2019-12-09
Brief Title:
Sleep Treatment for Addiction Recovery
Sponsor:
University of Missouri-Columbia
Organization:
University of Missouri-Columbia
Study Overview
Official Title:
The Impact of CBT for Insomnia on Substance Use Treatment Outcomes
Status:
UNKNOWN
Status Verified Date:
2022-03
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
STAR
Brief Summary:
Project STAR aims to examine the feasibility acceptability and initial efficacy of a CBT-I supplement to outpatient alcohol and substance use treatment
Detailed Description:
Among those who receive treatment for alcohol use disorder AUD one in three relapses to problematic drinking within one year of treatment Thus additional treatment strategies are needed Notably up to 74 of individuals seeking treatment for AUD report co-occurring symptoms of insomnia while 85 of those seeking SUD treatment report insomnia symptoms Given the negative impact of insomnia on attention and emotion regulation insomnia symptoms may decrease patients abilities to attend to treatment for substance use and manage negative emotions that lead to craving and relapse This project aims to examine the feasibility acceptability and initial efficacy of a CBT-I supplement to substance use treatment Forty adults who meet diagnostic criteria for AUD or SUD and Insomnia Disorder will receive Cognitive Behavioral Therapy for Insomnia CBT-I In order to generate hypotheses regarding the efficacy of CBT-I for individuals who are and are not engaged in substance use treatment we aim to recruit 20 participants who are engaged in substance use treatment through the community at baseline and 20 participants who are not Outcomes will be assessed at the end of the active intervention period 6 weeks and at 6 weeks post-intervention
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None